AstraZeneca is transforming cutting edge science into meaningful medicines. We have the global scientific expertise and reach to drive new medicines faster from discovery through development to market.
In Discovery, our more than 5,000 highly skilled scientists use state-of-the-art technology to identify high quality candidate drugs (CDs) Our scientists work across boundaries to exchange ideas, share best practice and make the most of the efficiencies that global collaboration offers.
Our North American Discovery sites focus on:
- Central nervous system (CNS) therapies in psychiatry
- Infectious diseases
- Cancer treatments
- Inflammatory and neuropathic pain, the two most common types of pain
The more than 6,000 people in our AstraZeneca Development organization guide potential new medicines through the pharmaceutical development process. They work globally in therapy area-led product teams that bring together all the relevant functional skills and experience needed for the rapid progress of new medicines.
